Arvinas Inc (ARVN)
Healthcare
Biotechnology
8.10 $
+0.4%
vs. previous close
Closing price · As of: 3. Aug 2026
Arvinas Inc (ARVN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -69 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -89 | -85 | -83 | -98 | 50 | -128 | -84 | -89 | -95 | -59 | -30 | -69 | -254 | |
| 1.6 | 1.7 | 1.7 | 1.7 | 1.7 | 1.6 | 1.6 | 1.3 | 1.4 | 1.3 | 1.2 | 1.1 | 5.0 | |
| 18 | 17 | 17 | 19 | 22 | 25 | 23 | 15 | 10 | 10 | 8.5 | 11 | 40 | |
| 18 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 5.7 | -35 | 59 | -43 | 67 | -104 | -60 | -188 | -43 | -33 | 30 | -1.0 | -47 | |
| 0.6 | 1.1 | 0.1 | 0.1 | 0.7 | 0.7 | 0.3 | 0.4 | 1.2 | 0.1 | 0.2 | 1.3 | 2.8 | |
| 49 | 70 | -54 | -128 | 13 | 51 | 99 | 70 | 129 | 64 | 146 | 14 | 352 | |
| – | – | – | – | – | – | – | – | – | -18 | -74 | – | – | |
| – | – | – | – | – | 0.0 | -0.1 | -0.1 | 0.0 | 0.0 | -0.1 | -0.1 | -0.2 | |
| 0.5 | 38 | 335 | 1.6 | 3.4 | 2.4 | 0.5 | -0.1 | 0.5 | -18 | -74 | -0.1 | -91 | |
| -40 | 23 | 198 | -224 | 67 | -75 | 15 | -20 | 34 | -13 | 41 | -56 | 6.3 | |
| -89 | -86 | -83 | -98 | 50 | -129 | -84 | -89 | -97 | -59 | -31 | -71 | -257 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.